Mesenchymal stem cell-based Smad7 gene therapy for experimental liver cirrhosis

BACKGROUND: Bone mesenchymal stem cells (MSCs) can promote liver regeneration and inhibit inflammation and hepatic fibrosis. MSCs also can serve as a vehicle for gene therapy. Smad7 is an essential negative regulatory gene in the TGF-β1/Smad signalling pathway. Activation of TGF-β1/Smad signalling a...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Dong-Na, Wu, Shi-Pin, Xu, Shang-Zhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489041/
https://www.ncbi.nlm.nih.gov/pubmed/32928296
http://dx.doi.org/10.1186/s13287-020-01911-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7489041/
https://www.ncbi.nlm.nih.gov/pubmed/32928296
http://dx.doi.org/10.1186/s13287-020-01911-4

Ejemplares similares